Integrative multi-omics characterization reveals sex differences in glioblastoma

ConclusionsCollectively, our study provides unprecedented insights into the fundamental modulators of tumor progression and clinical outcomes between male and female GBM patients and facilitates sex-specific treatment interventions.HighlightsFemale GBM patients were characterized by increased MGMT promoter methylation and favorable clinical outcomes compared to male patients.Female GBMs exhibited higher levels of genomic instability, including aneuploidy and TMB.Each sex-specific GBM is characterized by unique pathway dysregulations and molecular subtypes.EGFR activation is prevalent in male patients, while female patients are marked by SPP1 hyperphosphorylation.
Source: Biology of Sex Differences - Category: Biology Source Type: research